Iveric Bio Inc (ISEE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Sales | 209,977 | 50,909 | 51,505 | 41,259 | 0 |
| Gross Profit | 209,977 | 50,909 | 51,505 | 41,259 | N/A |
| Operating Expenses | 101,972 | 246,473 | 175,033 | 121,772 | 47,425 |
| Operating Income | 108,005 | -195,564 | -123,528 | -80,513 | -47,425 |
| Other Income | 1,488 | 1,738 | 1,024 | 217 | -3,720 |
| Pre-tax Income | 109,493 | -193,826 | -122,504 | -80,296 | -51,145 |
| Income Tax | -4,712 | -406 | -16,787 | 36,476 | N/A |
| Net Income Continuous | 114,205 | -193,420 | -105,717 | -116,772 | -51,145 |
| Net Income | $114,205 | $-193,420 | $-105,717 | $-116,772 | $-51,145 |
| EPS Basic Total Ops | 3.18 | -5.45 | -3.06 | -3.51 | -6.34 |
| EPS Basic Continuous Ops | 3.18 | -5.45 | -3.06 | -3.51 | -5.68 |
| EPS Diluted Total Ops | 3.17 | -5.45 | -3.06 | -3.51 | -6.34 |
| EPS Diluted Continuous Ops | 3.17 | -5.45 | -3.06 | -3.51 | -5.68 |
| EPS Diluted Before Non-Recurring Items | 3.17 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $110,908 | $-194,212 | $-119,982 | $-78,362 | $-47,317 |